Linio Biotech Named Among LSI’s Top 500 Emerging Medtech Innovators Worldwide
Linio Biotech has been included in the 2025 LSI Emerging Innovators Report, an annual publication highlighting 500 emerging medtech companies globally.
The LSI Emerging Innovators Report highlights high-potential medical technology companies shaping the future of healthcare. The report is widely regarded by investors, strategic partners, and industry leaders as a key benchmark for innovation, clinical impact, and growth potential within the medtech sector.
Linio Biotech’s inclusion reflects the strength of our regenerative skin science technologies and our commitment to advancing next-generation solutions in the medical aesthetic field.
We are proud to be recognized among the most promising emerging medtech companies globally and look forward to continuing to drive innovation in regenerative medicine.
Linio Biotech Named Among LSI’s Top 500 Emerging Medtech Innovators Worldwide
Linio Biotech has been included in the 2025 LSI Emerging Innovators Report, an annual publication highlighting 500 emerging medtech companies globally.
The LSI Emerging Innovators Report highlights high-potential medical technology companies shaping the future of healthcare. The report is widely regarded by investors, strategic partners, and industry leaders as a key benchmark for innovation, clinical impact, and growth potential within the medtech sector.
Linio Biotech’s inclusion reflects the strength of our regenerative skin science technologies and our commitment to advancing next-generation solutions in the medical aesthetic field.
We are proud to be recognized among the most promising emerging medtech companies globally and look forward to continuing to drive innovation in regenerative medicine.